Lifespan Extension Could Spur Regulatory and Pharma Changes
A
Aubrey de Grey during the Longevity Investors Conference 2024
Story of claim
A dramatic improvement in lifespan extension would mobilize regulatory changes and attract substantial investment from Big Pharma.
- Goal: Mobilize regulatory change and attract Big Pharma investment.
- Proof: Significant advances would pressure regulators to modernize and attract major investments.
- Nuances:
- Regulatory environment modernization
- Increased return on investment
- Robust Mass Rejuvenation as a goal
- Impact on Life: Potential for faster approval and availability of new treatments.
Investments
- Price: Estimation not available
- Time:
- Effort:
Risks
Regulatory hurdles may delay progress despite scientific advances.
Get Started 🚀
- Advocate for regulatory changes to support longevity research
- Participate in public discussions on lifespan extension
Brogevity AI can make mistakes. Check important info.